Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Elixir Department: SOP for Use of Mobile IPC Labs – V 2.0

Posted on By

Elixir Department: SOP for Use of Mobile IPC Labs – V 2.0

Standard Operating Procedure for Use of Mobile IPC Labs in Elixir Manufacturing

Department Elixir Department
SOP No. SOP/ELX/208/2025
Supersedes SOP/ELX/208/2022
Page No. Page 1 of 9
Issue Date 11/04/2025
Effective Date 15/04/2025
Review Date 11/04/2026

1. Purpose

To define the procedure for operation, maintenance, and utilization of Mobile In-Process Control (IPC) Laboratories during elixir manufacturing to enable real-time testing, faster decision-making, and regulatory compliance.

2. Scope

This SOP applies to the use of mobile IPC labs for conducting physical and chemical tests such as pH, weight per mL, clarity, and assay within the manufacturing area of the Elixir Department. It includes equipment handling, sample testing, documentation, and data transmission.

3. Responsibilities

  • QC Analyst:
    • Operate mobile lab equipment, perform testing, and document results.
  • Production Operator:
    • Coordinate sample provision and ensure space for mobile lab access.
  • QA Officer:
    • Verify test records and approve the use of results for batch decision-making.
See also  Elixir Department: SOP for Odor Check During Final Blending - V 2.0

4. Accountability

The QC Head is accountable for the operation and calibration of mobile IPC labs. QA ensures documentation, audit readiness, and compliance.

5.

Procedure

5.1 Setup of Mobile IPC Lab

  1. Verify that the mobile IPC trolley contains:
    • Portable pH meter
    • Analytical balance (portable)
    • Conductivity meter (if required)
    • Glassware, reagents, calibrated pipettes
    • Power supply and battery backup
  2. Ensure all instruments are calibrated and within validity period.
  3. Position mobile IPC lab near the manufacturing tank or designated IPC station.

5.2 Performing Tests

  1. Collect samples in pre-labeled containers as per the sampling plan.
  2. Perform the required tests (e.g., pH, weight per mL, clarity) within 15 minutes of sampling.
  3. Record the results directly into the IPC mobile lab logbook and/or electronic tablet (if used).
  4. Ensure test results are reviewed by QA before batch continuation.

5.3 Cleaning and Maintenance

  1. Clean all glassware and wipe down instruments with lint-free cloth post-usage.
  2. Disinfect surfaces using 70% IPA before moving between production areas.
  3. Check and charge backup batteries at the end of the shift.

5.4 Data Handling

  1. All data should be captured:
    • Manually in the Mobile IPC Logbook (Annexure-1)
    • Digitally using validated electronic systems (if available)
  2. Results must be transcribed into the BMR and signed by the analyst and QA.

5.5 Movement Protocol

  1. Before relocating the mobile IPC lab to a new batch or room:
    • Wipe all surfaces
    • Cover sensitive instruments
    • Secure mobile unit with brakes and stability locks during transport

6. Abbreviations

  • IPC: In-Process Control
  • SOP: Standard Operating Procedure
  • QA: Quality Assurance
  • QC: Quality Control
  • BMR: Batch Manufacturing Record
  • IPA: Isopropyl Alcohol

7. Documents

  1. Mobile IPC Lab Logbook (Annexure-1)
  2. Equipment Calibration Log
  3. Batch Manufacturing Record (BMR)

8. References

  • 21 CFR Part 211.110 – Sampling and Testing of In-Process Materials
  • ICH Q10 – Pharmaceutical Quality System
  • WHO TRS 986 – GMP Guidelines

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Mobile IPC Lab Logbook

Date Batch No. Parameter Result Specification Tested By QA Review
11/04/2025 ELX-0425-026 pH 6.9 6.5 – 7.5 Rajesh Kumar Sunita Reddy

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 1.0 Initial Release New SOP QA Head
11/04/2025 2.0 Inclusion of mobility and electronic data capture Process Optimization QA Head
Elixers V 2.0 Tags:Elixir colorants, Elixir dosage form, Elixir filtration techniques, Elixir flavoring agents, Elixir formulation, Elixir GMP compliance, Elixir manufacturing process, Elixir manufacturing SOPs, Elixir packaging requirements, Elixir pharmacopoeial standards, Elixir preparation methods, Elixir preservatives, Elixir production equipment, Elixir quality control, Elixir regulatory guidelines, Elixir shelf life, Elixir stability testing, Elixir sterilization methods, Elixir storage conditions, Elixir sweetening agents, Elixir viscosity modifiers, Hydroalcoholic solutions, Medicated elixirs, Non-medicated elixirs, Pharmaceutical elixirs

Post navigation

Previous Post: SOP Revision Workflow: A Step-by-Step Approach
Next Post: Analytical Method Development: SOP for Determination of Enteric Coating Integrity – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version